🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

'Mark Ramprakash & @PhilTufnell have been raising awareness with the Middlesex Seniors Cricket Team, around the importance of #cholesterol management, especially for those who have had a cardiovascular event, such as a heart attack or stroke. Watch here: fb.watch/mVmeaYTox8/

September is Blood Cancer Awareness Month, and we are thrilled to announce our new campaign about myeloproliferative neoplasms (#MPNs), called #MPN10! 10 suspects, 10 symptoms. Hit the link to reveal all 🕵🏻‍♂️ : novartis.com/uk-en/mpn10

Mural artists from around the UK have joined forces to portray MPN blood cancer symptoms at our new MPN 10 exhibition. See it live at Westfield London, White City on #MPNAwarenessDay (14th Sept) for one week only! Find out more 🕵🏻‍♂️: novartis.com/uk-en/mpn10

Discover our #MPN10 characters - learn their names, while understanding the symptoms and signs for MPN (myeloproliferative neoplasms) a rare form of blood cancer. Empower yourself with MPN awareness and find out more on our website: novartis.com/uk-en/mpn10. #mpns

Around 1 in 5 people have high levels of Lipoprotein(a), a risk factor for #CVD. As members of the Lp(a) Taskforce with HEART UK, read our Call to Action to screen for Lp(a) in clinical practice to improve #CVDprevention: bitly.ws/SnUM #NovartisOK

Over 41,000 people are diagnosed with blood cancer every year in the UK. We’re proud to support and partner with Blood Cancer Alliance, to help raise visibility of a cancer that remains widely unknown, and address the unmet needs that persist for these patients. #NovartisOK

#PatientPartnershipWeek aims to highlight how patients working with our health systems will create better outcomes for everyone. We’re proud to support Patients Association, who will host a number of free, online sessions with leading speakers. #NovartisOK #WorldPatientSafetyDay

While other countries have taken steps towards introducing newborn screening for Spinal Muscular Atrophy, the UK is lagging behind. Urgent action is needed to ensure early and pre-symptomatic diagnosis, increasing the potential to save and improve lives. #NovartisOK

Did you know that Spinal Muscular Atrophy (SMA) is the leading genetic cause of infant death in the UK? Introducing newborn screening is the fastest route to early and pre-symptomatic diagnosis of SMA, increasing the opportunity to save and improve lives. #NovartisOK

Spinal Muscular Atrophy – or SMA – is a rare, genetic neuromuscular condition that has a devastating impact on patients and families affected. Without early intervention, symptoms progress quickly and sadly, many babies will die or need permanent ventilation. #NovartisOK

The impact of a diagnosis of Spinal Muscular Atrophy (SMA) on both patients and their families is enormous – physically, emotionally and financially. That's why, at Novartis, we believe in the importance and urgency of introducing newborn SMA screening in the UK. #NovartisOK

If you’ve had cardiovascular event like a heart attack or stroke you should aim to test your #cholesterol every year. Mark Ramprakash and 💙 michaela nuttall RGN MSc spoke with patients Chetan and Sharath to hear how they got support after their heart attacks #NovartisOK HEART UK

Cholesterol management is crucial for those who have had a cardiovascular event, like a heart attack or stroke. For this #NationalCholesterolMonth, take a look below and head to bitly.ws/YjAw to learn more about how to keep on top of cholesterol levels. #NovartisOK

We are proud to support The King's Fund Annual Conference, where our own Nicole Kane, Solid Tumour Medical Director will join a panel of experts to discuss inequalities in #breastcancer diagnosis, treatment, and care. #KFAnnual #NovartisOK

We were pleased to be at #Anthropy23 this week, discussing trust, building a better, healthier society, and our role in achieving these goals. Anthropy is a unique event which gathers diverse leaders to spark innovation and accelerate pathways towards a more prosperous future!

Tackling health inequalities cannot be done alone; we must work together. This was the consensus from the expert panel – including our own Nicole Kane - at #KFAnnual Conference, where they discussed how collaboration is vital to tackle inequalities in breast cancer care.

#SpinalMuscularAtrophy (SMA) affects around 70 babies every year in the UK, with most not surviving beyond their second birthday. For those affected, #EveryMomentMatters which is why we are calling for the urgent introduction of newborn screening for SMA. #NovartisOK

Last week, experts from across the #SpinalMuscularAtrophy community came together to discuss how we can accelerate the introduction of newborn SMA screening in the UK. Read more in our report - coming soon. #NovartisOK

Last week, we were joined by Liz Twist MP as well as patient representatives, clinicians and other experts in #SpinalMuscularAtrophy, to discuss success factors for introducing SMA newborn screening to the UK. Here are our recommendations 👇 #NovartisOK

Building your self-love and confidence every day is hard, but it is even harder, when you were just diagnosed with #BreastCancer. Read more about Tricia, Kirsten, Nina and Iyna’s take on beauty and identity this #BreastCancerAwarenessMonth in our feature with Marie Claire. Find